Tenon Medical, Inc.
Healthcare sector | Medical Devices industry
Metrics for TNON
| Price | $0.76 |
|---|---|
| Shares Outstanding | 11.3M |
| All-Time Low | $0.64 |
| 52-Week Low | $0.64 |
Balance Statement Metrics
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $0.09 |
| Net Tangible Assets / Share | $0.19 |
| Shares Outstanding Ave Change (Annual) | 181.67% |
| Shares Δ YoY | 865.67% |
| Avg CA Burn (Annual %) | 24.85% (as of 4-5-2026) |
| Avg CA Burn (Quarterly %) | -0.47% (as of 4-5-2026) |
Earning Metrics
| Max Earning Power / Share | $-2.25 |
|---|---|
| Adjusted Earning Power |
$-2.39
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.86%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 0 (as of 4-5-2026) |
| Avg EBITDA (5Q) | 0 (as of 4-5-2026) |
| Avg Net Income (5Y) | -13.8M (as of 4-5-2026) |
| Avg Net Income (5Q) | -3.1M (as of 4-5-2026) |
Indicators
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 4-5-2026 |
| Consecutive Years Paid | No | 4-5-2026 |
| Pays Dividend | No | 4-5-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 4-5-2026 |
| Net Income Positive | No | 4-5-2026 |
| Current Dividend Streak | No | 4-5-2026 |
Metric History Explorer
Pick a metric to view its history table and chart.
Tangible Book Value Per Share History
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $-0.09 | -926K ($-926,000) | 10.9M (10,851,273) |
| 2025-09-30 | Quarterly | $-0.14 | -1.2M ($-1,183,000) | 8.6M (8,605,508) |
| 2025-06-30 | Quarterly | $0.39 | 3M ($2,961,000) | 7.6M (7,592,217) |
| 2025-03-31 | Quarterly | $0.74 | 5.6M ($5,624,000) | 7.6M (7,589,965) |
| 2024-12-31 | Quarterly | $0.71 | 2.2M ($2,219,000) | 3.1M (3,138,804) |
| 2024-12-31 | Annual | $0.71 | 2.2M ($2,219,000) | 3.1M (3,138,804) |
| 2024-09-30 | Quarterly | $1.42 | 4.4M ($4,439,000) | 3.1M (3,136,013) |
| 2023-12-31 | Annual | $2.39 | 778K ($778,000) | 325K (325,038) |
| 2022-12-31 | Annual | $44.51 | 6.3M ($6,252,000) | 140.5K (140,460) |
| 2021-12-31 | Annual | $-146.32 | -20.6M ($-20,552,000) | 140.5K (140,460) |
Revenue History (Annual)
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 3.3M ($3,277,000) |
| 2023-12-31 | 2.9M ($2,928,000) |
| 2022-12-31 | 691K ($691,000) |
| 2021-12-31 | 160K ($160,000) |
Dividend Payments
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
Shares Outstanding Changes
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-04-06 | 11,296,378 | +445,105 |
| 2026-03-26 | 10,851,273 | -255,171 |
| 2025-12-11 | 11,106,444 | +282,800 |
| 2025-11-26 | 10,823,644 | +2,217,904 |
| 2025-11-20 | 8,605,740 | +2,748 |
| 2025-09-29 | 8,602,992 | -276,228 |
| 2025-08-22 | 8,879,220 | +987,000 |
| 2025-08-15 | 7,892,220 | +302,250 |
Short Interest Changes
Latest short-interest change: 234,577 shares (2.27% of float) | Days to cover: 1.20
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-04-27 | 234,577 shares | -11,610 | -4.72% |
| 2026-04-17 | 246,187 shares | +55,143 | +28.86% |
| 2026-03-25 | 191,044 shares | -78,973 | -29.25% |
| 2026-03-12 | 270,017 shares | -564,861 | -67.66% |
| 2026-02-27 | 834,878 shares | +755,277 | +948.83% |
| 2026-02-11 | 79,601 shares | +29,856 | +60.02% |
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| 2026-02-09 | 45,054,960 | 11,106,444 | 405.67% | $0.82 |
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.